-
Chinese mainland reports no new locally transmitted COVID-19 cases
2021-03-01
The Chinese mainland reported no new locally transmitted COVID-19 cases on Feb 28, the National Health Commission said March 1.
-
New vaccine to 'provide 2-year protection'
2021-03-01
An adenovirus vector vaccine against COVID-19 by CanSino Biologics is projected to provide protection for two years if a booster shot is administered, said a scientist who played a key role in the vaccine's development.
-
NMPA grants conditional approval to CanSino’s recombinant COVID-19 vaccine
2021-02-27
The National Medical Products Administration (NMPA) conditionally approved the registration application of the recombinant COVID-19 vaccine (adenovirus type-5-vectored vaccine) developed by CanSino Biologics on Feb 25.
-
NMPA conditionally approves COVID-19 vaccine developed by Sinopharm's Wuhan institute
2021-02-27
The National Medical Products Administration (NMPA) conditionally approved the registration application of the inactivated COVID-19 vaccine (Vero cell) developed by the Wuhan Institute of Biological Products administered by Sinopharm on Feb 25.
-
Chinese mainland reports no new locally transmitted COVID-19 cases
2021-02-26
The Chinese mainland reported no new locally transmitted COVID-19 cases on Thursday, the National Health Commission said on Feb 26.
-
Chinese mainland reports no new locally transmitted COVID-19 cases
2021-02-25
The Chinese mainland reported no new locally transmitted COVID-19 cases on Wednesday, the National Health Commission said on Feb 25.
